This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Raphael Levy: Innovator in Antibody Drug Conjugates
Introduction
Raphael Levy is a prominent inventor based in Princeton, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapies.
Latest Patents
Levy holds a patent for "ANTI-CEACAM5 ANTIBODY DRUG CONJUGATES." This invention represents a breakthrough in targeted cancer therapies, showcasing his expertise in antibody-drug conjugate technology. He has 1 patent to his name, reflecting his commitment to advancing medical science.
Career Highlights
Levy is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at Bristol-Myers Squibb has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to innovative drug development.
Collaborations
Some of his notable coworkers include Akbar Nayeem and Ruchira Dasgupta. Together, they work on various projects aimed at improving patient outcomes through innovative therapies.
Conclusion
Raphael Levy's work in the field of antibody drug conjugates exemplifies the impact of innovation in biotechnology. His contributions continue to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile